esao-ifao · pdf fileafter decades of development, the artificial and...

ESAO-IFAO 2017 Sponsors

2

Sponsors

Platinum Sponsor

Gold Sponsor

Silver Sponsors

Bronze Sponsors

Sponsors

ESAO-IFAO 2017 Contents

3

Contents

Introduction and Addresses

Sponsors ........................................................................................................................................................... 2

Contents ........................................................................................................................................................... 3

Boards and Committees ................................................................................................................................... 4

Welcome Message ........................................................................................................................................... 5

Presidential Address – ESAO President ............................................................................................................ 6

Presidential Address – IFAO President ............................................................................................................. 7

Program Overview and Information

Program at a Glance ......................................................................................................................................... 8

Congress Venue ..............................................................................................................................................12

Floor Plan ........................................................................................................................................................13

Helpful Information ........................................................................................................................................14

Social Program and Side Events

Social Program ................................................................................................................................................15

yESAO 2017.....................................................................................................................................................17

ICCAC/ESAO MCS Proficiency Course .............................................................................................................18

Detailed Progam

Program – Tuesday .........................................................................................................................................20

Program – Wednesday ...................................................................................................................................20

Program – Thursday Morning .........................................................................................................................21

Program – Thursday Afternoon ......................................................................................................................23

Program – Friday Morning ..............................................................................................................................29

Program – Friday Afternoon ...........................................................................................................................32

Program – Saturday ........................................................................................................................................38

Impressum ......................................................................................................................................................43

Welcome Message

ESAO-IFAO 2017 Boards and Committees

4

Boards and Committees

XLIV ESAO and VII IFAO CONGRESS, 6-9 SEPTEMBER 2017, VIENNA, AUSTRIA

Boards and Committees

ESAO President Honorary ESAO President Thomas Groth Horst Klinkmann

IFAO President ASAIO President JSAO President Bernd Stegmayr William Fissell Yoshiyuki Taenaka

Local Organizing Committee

Congress President: Heinrich Schima

Honorary Congress President: Udo Losert

Program Chairs:

Cardiac: Francesco Moscato & Daniel Zimpfer Dialysis: Bruno Watschinger

Apheresis: Viktoria Weber & Volker Witt Tissue Engineering: Helga Bergmeister & Heinz Redl

Prosthetics, Functional Electrical Stimulation: Manfred Bijak & Winfried Mayr VAD – Clinicians: Thomas Schlöglhofer

yESAO: Martin Maw & Philipp Aigner

Office: Christian Grasl, Ursula Kurzreiter, Melitta Pichler, Martin Stoiber Congress Agency: Conventive OG

International Scientific Committee

Angel Argiles (France) Stephen Ash (USA) Oskar Aszmann (Austria) Georg Böhmig (Austria) Andrea Buscaroli (Italy) Juan Canizo (Spain) Gerardo Catapano (Italy) Gerald Cohen (Austria) Richard Crevenna (Austria) Marek Darowski (Poland) Kurt Dasse (USA) Arianna Di Molfetta (Italy) Wolfgang Drexler (Austria) Sunny Eloot (Belgium) Giuseppe Faggian (Italy) Michael Fischer (Austria) Gloria Gallego-Ferrer (Spain) Birgit Glasmacher (Germany) Marcus Granegger (Switzerland) Jens Hartmann (Austria) Shigehiro Hashimoto (Japan) Christopher Hayward (Australia) Michael Hiesmayr (Austria) William Holman (USA)

Joachim Jankowski (Germany) Cornelia Kasper (Austria) Tim Kaufmann (Germany) Ulrich Kertzscher (Germany) Ashraf Khir (Great Britain) Hendrik Kuhlmann (Austria) Piotr Ladyzynski (Poland) Hermann Lanmüller (Austria) Günther Laufer (Austria) Cécile Legallais (France) Edward Leonard (USA) Bengt Lindholm (Sweden) Robert Liska (Austria) Christiane Marko (Austria) Toru Masuzawa (Japan) Kenichi Matsuda (Japan) Ares Menon (Germany) Paul Mohasci (Switzerland) Alessandra Molteni (Great Britain) Khosrow Mottaghy (Germany) Marc Müller (Germany) Nuno Neves (Portugal) Takashi Nishimura (Japan) Tomhiro Nishinaka (Japan)

Bruno Podesser (Austria) Christine Radtke (Austria) Dietmar Rafolt (Austria) Ruis Reis (Portugal) Andrea Remuzzi (Italy) Aleksander Sikole (Macedonia) Alfredo Soldati (Austria) Simon Sonntag (Germany) Andreas Spittler (Austria) Dimitrios Stamatialis (Netherlands) Sergio Stefoni (Italy) Ulrich Steinseifer (Germany) Koichi Toda (Japan) Maria Trivella (Italy) Roman Ullrich (Austria) Tom Verbelen (Belgium) Joerg Vienken (Germany) Beat Walpoth (Switzerland) Dominik Wiedemann (Austria) Johann Wojta (Austria) Ernst Wolner (Austria) Peter Zilla (South Africa) Andreas Zuckermann (Austria)

Welcome Message

5

Welcome Message Welcome to the World Meeting on Artificial Organs, the ESAO-IFAO-2017-Congress

Dear Colleagues, the Vienna Team and I cordially invite you to the ESAO-IFAO-2017-Congress, the World Congress for Artificial Organs. After decades of development, the artificial and bioartificial replacement and support of organs has become clinical routine in many important applications. From desperate attempts many therapies such as dialysis and apheresis, cardiac assist devices, ECMO,

insulin pumps and advanced limb prostheses arose to the center of medicine. Instead of providing only survival and basic organ support, quality of life and even “forgettability” have become the focus of further developments. The motto of this meeting in Vienna, a city of music: “Artificial Organs in the Orchestra of Life” underlines this widening horizon. This however implies an increasing cost pressure, tighter requirements for absolute safety and liability, regulatory improvements and hurdles, and sometimes stakeholders with different interests.

Thanks to you all, we have received more than 300 abstracts, and could accepted proposals for 24 symposia for a wide range of topics. This meeting is a true intercontinental one, bringing together researchers, developers, clinicians and regulatory people from all over the world to discuss these questions on a global level. The meeting shall also support scientific and personal networking in a world with increasing tensions and egoisms to work successfully together on the welfare of our patients and societies. Evening events such as a typical Viennese vineyard cellar (Heuriger), a visit to two famous medical museums (with a special exhibition about 50 years of cardiovascular support) shall stimulate social contacts. The first worldwide recipient of one of the most advanced cardiac assist devices and now transplanted opera singer, Gregory Petkov will accompany the opening ceremony. We are looking forward to welcome you in Vienna! With best greetings, Heinrich Schima Congress President

ESAO-IFAO 2017 Presidential Addresses

6

Presidential Address – ESAO President It is my great pleasure to welcome you to the World Congress of Artificial Organs in Vienna, Austria from September 6-9, 2017, which is at the same time the 44th Congress of European Society for Artificial Organs and the 7th of International Federation of Artificial Organs organized by Prof. Heinrich Schima as Congress President and his team with strong support from Medical University Vienna and the Ludwig Boltzmann Cluster for Cardiovascular Research. I welcome congress participants who submitted abstracts and will present their latest research from all over the world with guests from Australia, Brazil, China, Japan and United

States, but also from European countries including a strong participation from Eastern Europe like Poland, the Russian Federation, Ukraine and others. It demonstrates not only how attractive congresses of ESAO have become, but is also a reflection of need and interest for international collaboration and exchange of ideas in times when tendencies are growing to separate people again. This year’s theme of the congress “Artificial Organs in the Orchestra of Life” is not only a reminiscence to the famous composers who lived and worked in Vienna, but also to eminent scientists and physicians who made major contributions to medicine, physics, biology including many Nobel Laureates from Austria. Hence, Vienna is an inspiring venue to meet and discuss latest achievements in the area of artificial organs that is highly interdisciplinary orchestrating collaboration of material scientists, physicists, biologists, engineers and physicians. Topics of artificial organ therapy like cardiac support, hemodialysis and apheresis, vascular tissue engineering, but also issues like artificial lung and respiratory support and emerging disciplines like bioartificial organs, nanomedicine, regenerative medicine, the functional stimulation of nerves and muscles and the development of intelligent limb prostheses will be discussed in plenary lectures, oral sessions and many special symposia and represent the joint effort of scientists, engineers and physicians worldwide to improve therapies for our patients. The organizer achieved to arrange an excellent program with world-class plenary speakers, invited lectures from distinguished specialist, and more than 300 oral and poster presentations. The Chairs of young ESAO, Alessandra Molteni and Marc Müller will organize a pre-congress meeting starting on September 5, 2017 with the motto “The Grand Waltz of Artificial Organs – Spinning Circles between Challenges and Solutions” to provide an excellent platform for our young researchers to meet each other and to discuss their latest research with more experienced scientists, who will contribute with tutorial lectures. Those of you who do not belong to the European Society of Artificial Organs yet, are cordially invited to become a member and join our activities on development of artificial organ technology, tissue engineering and regenerative medicine. We also invite all participants to submit their research results as presented during this congress to the flagship of our society – The International Journal of Artificial Organs. Vienna, the capital of Austria is a town of long and amazing history represented by many historical places, museums with exciting exhibitions and also architectural preciouses that are outstanding like Emperors palaces and many famous Art Nouveau buildings. A reflection of the multicultural history of Vienna is also the Austrian cuisine, coffee house culture and art in wine production, which represent further reasons why the visit of the ESAO Congress in Vienna is hopefully a must for you. Last, but not least the hospitality of Austrian people is well known and Heinrich Schima and his team organized an exciting social program not only for accompanying persons but also for all congress participants. I am quite confident that you will agree that these are good reasons to attend the World Congress of Artificial Organs organized jointly by ESAO and IFAO with our close friend and colleague Heinz Schima as Congress President. Hence, I hope that I will see you in Vienna from September 6-9, 2017. A warm welcome Prof. Thomas Groth President of European Society for Artificial Organs

ESAO-IFAO 2017 Presidential Addresses

7

Presidential Address – IFAO President

We are very proud to invite you to the ESAO-IFAO congress 2017 hosted by Congress president Heinrich Schima and his college’s in Vienna. The congress will offer a broad variety of artificial organ topics. The IFAO (International Federation of Artificial Organs) this year has a joint venture congress with the ESAO. The focus for IFAO is to bridge aspects of artificial organ research and conditions over the continents. Thereby presenters and attendants from member societies of IFAO as the Japanese Society (JSAO) and the American Society (ASAIO) will be participating in the program and congress. Economical support will be available for young attendants from

JSAO and ASAIO. The evaluations are made be members from the 'home' societies. Have a look at the present program and consider the importance to update your knowledge. In addition you will be able to share your experience with researchers from many countries and various disciplines as well as having opportunity to discuss with experts from industry. As you might notice there are several parallel sessions that might interest you. Why not bring some colleges from your institute to help cover the various fields. Besides the scientific offers, with many invited expert lecturers, you will also have the opportunity to visit this wonderful city. Warmely welcome, Bernd Stegmayr IFAO President

ESAO-IFAO 2017 Program at a Glance

8

Program at a Glance

Tuesday, September 5

Start End

12:30 18:00

Pre-

Cong

ress

M

eetin

g: Room 7

yESAO (I) – "The Grand Waltz of Artificial Organs" Spinning Circles Between Challenges and Solutions

20:00 23:00 yESAO Come Together

Wednesday, September 6

Start End

09:00 12:00

Pre-

Cong

ress

Mee

tings

:

Room 7/8 yESAO (II)

Room 12 ESAO Board

Meeting (Board Members only)

Room 23/24/25 ICCAC/ESAO MCS Proficiency Course

12:00 13:00 Lunch

13:00 15:30 Room 7 yESAO (III)

Room 10/12 ESAO / IFAO

Board Meeting (Board Members only)

Room 23/24/25 ICCAC/ESAO MCS Proficiency Course

16:00 18:00

Hall 1 Opening Ceremony

Chairs: H. Klinkmann, U. Losert

Presidential Address Challenges in the field of Artificial Organs

H. Schima

Welcome Adresses IFAO President:

ESAO President: Ludwig Boltzmann Society:

Medical University of Vienna:

B. Stegmayr T. Groth C. Lingner President M. Müller

Award Ceremony ESAO Wichtig Research Award, ESAO PhD Award,

IFAO Transcontinental Travel Scholarships, yESAO Exchange Program Award

Opening Lecture Bioinspired Engineering: From Human Organs-on-Chips

to Dialysis-Like Therapeutic Devices Donald E. Ingber, Harvard University

Musical Performance Opera Singer and first recipient of the Heartware® HVAD

G. Petkov accompanied on the piano by P. Stoianov

18:30 21:00 Conference Venue - Welcome Reception and Buffet


9

Thursday, September 7

Start End Hall 2 / Hörsaal 2 Hall 4 / Hörsaal 4 Hall 3 / Hörsaal 3 Hall 5 / Hörsaal 5

08:30 09:30

A11 Symposium: Challenges in

Development and Application of VADs

B11 Liver Failure

C11 Biomaterials I:

Hard Tissue Replacement

D11 Symposium:

Limb Prostheses

09:30 10:30

Hall 1 / Hörsaal 1 Plenary Lecture 1: The future of Mechanical Cardiac Support

J. Long, Oklahoma, US Plenary Lecture 2: Development of Complex Air-way Tissue Models

H. Walles, Würzburg, DE

10:30 11:00 Hallway - Coffee Break

11:00 12:30

A12 Heart and Pump:

Modelling and Control

B12 Materials in

Apheresis and Dialysis

C12 Symposium:

Tissue Regeneration (in cooperation with

TERMIS)

D12 Symposium:

New Aspects of Albumin (Albunet)

12:30 14:00 Hall 1 / Hörsaal 1

LS1 - Lunch with Corporate Member Symposium: Optimizing Hemocompatibility – Opportunity and Challenge for Developers

14:00 15:30

A13 Symposium: ICCAC-ESAO

International VAD Coordinators

B13 Symposium:

Citrate Anticoagulation

C13 Tissue Engineering

& Regenerative Medicine I

D13 Symposium:

Cardiac Valves

15:30 16:30 Hallway Level 8 – Poster Session I and Visit Exhibition with Coffee Break

16:30 18:00

A14 Experimental

Models for Cardiovascular

Devices

B14 Challenges for

Dialysis Devices

C14 Symposium: Challenges in

Vascular Tissue Engineering

D14 Symposium: Numerical

Modelling in Hemodialysis

18:00 21:30

Josephinum / Narrenturm Social Program - Tour to Medical Museums,

including a special exhibition on "Artificial Hearts - Bridge to Survive"


10

Friday, September 8


08:30 09:30 A21

Heart Regeneration and Transplantation

B21 Symposium:

Extracellular Vesicles

C21 Biomaterials II:

Soft Tissue Replacement

D21 Blood Trauma

09:30 10:30

Hall 1 / Hörsaal 1 Plenary Lecture 3: The Bionic Hand: Coupling the Brain to Prostheses

O. Aszmann, Vienna, AT Plenary Lecture 4: Mechanical Cardiac Support and Cardiac Rhythm Management:

A Marriage of two Technologies M. Hess, Minneapolis, US


11:00 12:30

A22 Symposium: Numerical

Modelling: Design, Optimization and

Functional Characterization of

VADs

B22 Emerging

Applications in Extracorporeal

Therapies

C22 Symposium:

Nanomedicine

D22 Symposium:

Regulatory Affairs

12:30 13:30

Hall 1 / Hörsaal 1 Lunch with Plenary Lecture 5:

Dialysis: From an Awkward, Complicated Method to a Mass-Therapy and Beyond E. Leonard, New York, US

13:30 15:30

A23 Symposium:

Blood damage in Rotary Assist

Devices

B23 Symposium:

Dialysis of Today and Tomorrow

C23 Tissue Engineering &

Regenerative Medicine II

D23 Symposium:

Artificial Lung

15:30 16:30 Hallway Level 8 – Poster Session II and Visit Exhibition with Coffee Break

16:30 18:00 A24

Computational Fluid Dynamics I

B24 Transplantation

Related Aspects of Dialysis

C24 "Bioartificial

Organs" Working Group

D24 Clinical Reports &

Exercise

18:00 19:00 Hall 3 – ESAO General Assembly (for members only)

20:00 23:00 Social Program – Heurigen Evening


11

Saturday, September 9


08:30 09:30 A31

Computational Fluid Dynamics II

B31 Uremic Toxins I


Regenerative Medicine III

D31 3D Additive

Manufacturing & Biofabrication

09:30 10:30

Hall 1 / Hörsaal 1 Plenary Lecture 6: Apheresis for Dilated Cardiomyopathy

J. Winters, Rochester, US

Plenary Lecture 7: Medical Device Innovation in Asia and Japan - Present and Future Strategy Yoshiyuki Taenaka, Tokyo, JP


11:00 12:30

A32 Symposium: Challenges in

Tailoring a Rehabilitation

Program for LVAD Patients

B32 Uremic Toxins II


Regenerative Medicine 4

D32 VADs:

The Next Generation

12:30 13:00 Hall 1 / Hörsaal 1 Closing / Adjourn

Presentation of ESAO Innovation Award and ESAO Poster Awards

13:00 14:30 Hallway - Farewell Lunch

ESAO-IFAO 2017 Congress Venue

12

Congress Venue The congress venue is located in the ‘Hörsaalzentrum’ of the Medical University of Vienna at the Vienna General Hospital on level 7 and level 8 of the building. The main entrance is situated on level 5.

Address: Vienna General Hospital (AKH) Währinger Gürtel 18-20 1090 Vienna, Austria How to reach the congress venue Underground: Line U6 stop Michelbeuern/AKH Tramway: Line 5 stop Lazarettgasse Tramway: Line 33 stop Lazarettgasse

ESAO-IFAO 2017 Floor Plan

13

Floor Plans

ESAO-IFAO 2017 – Program Helpful Information

14

Helpful Information Registration & Information Desk (Hallway, Level 7) The registration and information desk is located in the congress venue on level 7 and the stuff is happy to answer question. The conference material, name badges and certificates of attendance can be picked up there. If CME Credit points are required please sign in before the meeting at the registration desk. Speaker Preparation Desk (Room 11, Level 7) The speaker preparation desk must be used to hand in power-point slides for the oral presentations latest 2 hours before the start of the session. Private computers will not be allowed to connect to the beamers in the audience halls. Presentation Guidelines Guidelines for the poster & oral presentation can be found online via www.esao2017.org. Tickets for the Social Program The welcome reception and the museum evening are included in the congress fee. Tickets for the ‘Heurigen-Evening’ were sold via the registration. Remaining tickets may be available at the registration desk on a first-in-first-served basis. Awards During the conference several of awards will be presented:

• ESAO-Wichtig Research Award • IFAO Transcontinental Travel Scholarships • ESAO Poster Awards • ESAO Innovation Award • ESAO PhD Award • yESAO Exchange Program Award

Catering Refreshments during the coffee breaks and poster sessions and lunches will be provided. Lunch on Thursday and Friday will be offered in boxes to allow participation in the lunch sessions. On Saturday a farewell party with goulash and Würstel will be offered at noon. Internet Access Internet is available with the congress venue via the following WIFI-network.

Network: MUW-Guest GuestID: g81tschl Passwort: wuGEx67U

Smoking Smoking is prohibited in all hospital areas. Congress Organization Organizing Institution: Ludwig Boltzmann Gesellschaft Nußdorferstr. 64, 6. Stock, A-1090 Wien Tel: +43 1 5132750 Fax: +43 1 5132310 Email: [email protected]

Congress Agency: Conventive OG Leopold-Gattringerstr. 7/10 2345 Brunn am Gebirge Tel: +43 2236 38 27 32 Fax: +43 274 222 210 015 Mail: [email protected]

ESAO-IFAO 2017 Social Program – September 6 and 7

15

Social Program Wednesday, September 6 – Come-Together After the opening session on Wednesday at the Congress center of the Medical University of Vienna a come-together with buffet will be offered.

Thursday, September 7 – Medical Museums Evening On Thursday evening the congress will have the opportunity to visit two famous Viennese medical museums. Admission to the museums is free of charge and the order of visits might be based on individual choice.

The Josephinum was built in 1785, together with the first Vienna General Hospital. It includes a large collection of wax models for anatomical education and several collections of historical medical devices. In 2017 a special exhibition at the Josephinum will be dedicated to the development of artificial hearts and cardiac assist devices – a perfect fit to our congress.

A second museum is placed within the ‘Narrenturm’ (Fool’s Tower), a round building which is said to look like a ‘Gugelhupf’, a traditional Viennese cake.

Today it comprises a museum of the history of anatomy and pathology, including impressive and even shocking tissue preparations of famous diseases.

How to get there:

ESAO-IFAO 2017 Social Program – September 8

16

Friday, September 8 – Congress Dinner – Heurigen Evening On Friday the congress dinner will take place at a traditional Viennese ‘Heurigen’.

‘Heurige’ have a long tradition over several centuries and are known for their relaxing atmosphere. Buses will leave from the bus stop next to the main entrance of the general hospital at 19:30.

They are located near the Vienna Woods, and provide young wine, good food, and good specific music. This evening should provide an excellent opportunity to meet old and new friends.

The attendance fee includes food, drinks and transport from and back to the congress center. Location: Heuriger Wolff Rathstraße 46-50 1190 Vienna

© Heuriger Wolff

© Heuriger Wolff

yESAO Flyer

17

yESAO 2017

ESAO-IFAO 2017 ICCAC/ESAO MCS Proficiency Course Wednesday, September 6

18

ICCAC/ESAO MCS Proficiency Course Wednesday, September 6 09:00-12:00 and 13:00-15:30, Level 08 Room 23, 24, 25 (Kursraum 23, 24, 25) Chairs: Thomas Schlöglhofer Medical University of Vienna, Austria Dawn Christensen Innovative Program Solutions LLC, Pine Grove, USA Faculty: Pamela Combs Advocate Christ Medical Center, USA Friedrich Kaufmann German Heart Center, Berlin, Germany Johann Horvat Medical University of Vienna, Austria Jodie Lantz Children´s Health Dallas, USA Heather Moody University of Louisville, USA Katrien Vandersmissen UZ Leuven, Belgium Tonya Elliott MedStar Washington Hospital Center, USA Gro Sørensen Oslo University Hospital, Norway Roman Kustosz Clinic Zabrze, Poland Harald Schwingenschlögl Medical University of Vienna, Austria Mark Puhlman Providence St Vincent’s, Portland, USA Program Overview:

Time HVAD KR25

HM II and HM 3 KR24

BerlinHeart and OR KR23

09:00 Introduction - Session Instructions (KR23)

09:15 -

10:45

S1 Session 1 S2 Session 1 S3 Session 1 S4 Session 1



Switch Rooms 11:00 S1 Session 2

S2 Session 2 S5 Session 2 S6 Session 2

S9 Session 2 S10 Session 2 -

11:45 12:00

Lunch Break - 12:45 13:00 S3 Session 2

S4 Session 2 S7 Session 2 S8 Session 2

S11 Session 2 S12 Session 2 -

13:45

Switch Rooms

14:00 -

15:30




ESAO-IFAO 2017 ICCAC/ESAO MCS Proficiency Course

Wednesday, September 6

19

Course Description: • This course utilizes a small group construct in which participants proceeded through 3 separate stations over

the 6 hour course. These stations consist of problem based learning scenarios designed to reinforce critical thinking skills necessary to care for an advanced heart failure patient who is supported by a MCS device.

• Each station is 90min in length and will be repeated 3 times throughout the day (including 4 scenarios, each 20min).

• 3 stations will be in progress in each of the time slots throughout the day in 3 different rooms allowing for a maximum of 45 participants.

• Participants will be assigned to a group of no more than 15 individuals to encourage participation by attendees. Group interaction and discussion is the basis for success in this educational experience.

• Scenarios will be run by International VAD Coordinator Faculty.

Scenario Topics:

Device Topic (Room) Faculty Names Scenario Topics*

Medtronic HVAD (KR25)

G. Sørensen S1: Outflow graft thrombosis T. Schlöglhofer S2: Pump thrombus R. Kustosz S3: Waveform interpretation K. Vandersmissen S4: Driveline infection

Abbott HM II and HM 3 (KR24)

M. Puhlman S5: Controller malfunction T. Elliott S6: Aortic insufficiency F. Kaufmann S7: Outflow graft torsion H. Moody S8: Arrhythmia and RV failure

BerlinHeart and OR (KR23)

J. Lantz S9: EXCOR poor ejection H. Schwingenschlögl S10: EXCOR poor filling J. Horvat S11: EXCOR pump exchange P. Combs S12: HVAD and HM 3 wet test

* Scenario topics are tentative and subject to change.

ESAO-IFAO2017 – Programm Tuesday and Wednesday, September 5 and 6

20

Program – Tuesday

Tuesday, September 5 / 12:30-18:00 / Room 7

PC1 PreCongress Meeting: yESAO (I) 12:00-12:00 "The Grand Waltz of Artificial Organs" –

Part II Please find detailed program on page 17.

20:00 yESAO Come Together

Program – Wednesday Wednesday, September 6 / 09:00-12:00 / Room 7/8

PC2 PreCongress Meeting: yESAO (II) 09:00-12:00 "The Grand Waltz of Artificial Organs" –

Part II Please find detailed program on page 17.

Wednesday, September 6 / 09:00-12:00

Rooms 23, 24, 25

PC3 PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

Chair 1 T. Schlöglhofer; Vienna, AT Chair 2 D. Christensen; Pine Grove, US 09:00-12:00 Six stations and scenarios

Separate ticket required. Please find detailed program on pages 18-19.

Wednesday, September 6 / 09:00-12:00 / Room 12

ESAO Board Meeting


LU Lunch

Wednesday, September 6 / 13:00-15:30 / Hall 7

PC4 PreCongress Meeting: yESAO (III) 13:00-15:30 "The Grand Waltz of Artificial Organs" –

Part III Please find detailed program on page 17.


Rooms 23, 24, 25

PC5 PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

Chair 1 T. Schlöglhofer; Vienna, AT Chair 2 D. Christensen; Pine Grove, US 09:00-12:00 Six stations and scenarios

Separate ticket required. Please find the detailed program on pages 18-19.


Rooms 10/12

ESAO/IFAO Board Meeting Wednesday, September 6 / 16:00-18:00 / Hall 1

OC Opening Ceremony Chair 1 H. Klinkmann; Rostock, DE Chair 2 U. Losert; Vienna, AT Presidential Address H. Schima; Vienna, AT Welcome Address of the IFAO President B. Stegmayr; Umea, SE Welcome Address of the ESAO President T. Groth; Halle, DE Welcome Address of the General Manager of the Ludwig Boltzmann Society C. Lingner; Vienna, AT Welcome Address of the President of the Medical University of Vienna M. Müller; Vienna, AT ESAO Wichtig Research Award and ESAO PhD Award A. Remuzzi, M. Zucchetti

OL Bioinspired Engineering: From Human Organs-on-Chips to Dialysis-Like Therapeutic Devices D. Ingber; Boston, US Musical Performance by G. Petkov (Opera Singer and 1st recipient of the Heartware HVAD) accompanied on the piano by P. Stoianov

ESAO-IFAO 2017 - Program Thursday, September 7 – Morning Sessions

21

Program – Thursday Morning Thursday, September 7 / 08:30-09:30 / Hall 2

A11 Symposium: Challenges in Development and Application of VADs (sponsored by Medtronic Inc.)

Chair 1 J. Long; Oklahoma City, US Chair 2 G. Laufer; Vienna, AT 08:30 IL Challenges of minimal invasive implants

D. Zimpfer; Vienna, AT

08:45 IL Intelligent Monitoring of Patients and their VADs F. Moscato; Vienna, AT

09:00 IL Control of LVADs: The Native Heart Load Control System (NHLCS) T. Nishimura; Tokyo, JP

09:15 IL Analytic reports from J-MACS: Focusing on the differences from the results of other VAD registries M. Ono; Tokyo, JP

Thursday, September 7 / 08:30- 09:30 / Hall 4

B11 Liver Failure Chair 1 P. Ladyzinski; Warsaw, PL Chair 2 M. Fischer; Krems, AT

08:30 O1 MARS efficiency according to treatment modalities: Experience in patients affected by acute-on-chronic liver failure (ACLF) and comparison with data reported in the literature R. Marangoni; Como, IT

08:42 O2 Molecular Adsorbent Recirculating System (MARS) in acute liver injury and graft dysfunction: Results from a case control study H. Gerth; Muenster, DE

08:54 O3 Effects of normothermic liver perfusion after 1 hour of warm ischemia I. Fernandez-Lopez; Madrid, ES

09:06 O4 Liver functionality model during normothermic perfusion A. Rivera; Madrid, ES

Thursday , September 7 / 08:30-09:30 / Hall 3

C11 Biomaterials I: Hard Tissue Replacement Chair 1 R. Gruber; Vienna, AT Chair 2 S. Iwanaga; Toyama, JP

08:30 O5 Structure and properties of carbon fiber-reinforced hydroxyapatite composite matrix N. Arkharova; Moscow, RU

08:40 O6 Supramolecular gelatin nano-composites with enhanced sol-gel transition temperature M. Mohseni Moghaddam; Tehran, IR

08:50 O7 Experimental investigation and numerical analysis of the PMMA-based biocompatible vertebral cement flow D. Obidowski; Lodz, PL

09:00 O8 Transformation of Hydrogel Scaffolds using Ultrashort Laser Pulses for Tissue Engineering M. Savelyev; Zelenograd, RU

09:10 O9 Osteo-balls with Organic-Inorganic Chimeric Hydrogel Microbeads for Rapid Bone Formation S. Iwanaga; Toyama, JP

09:20 O10 Bone ingrowth in macro porous tricalcium phosphate implants produced by lithography-based ceramic manufacturing (LCM) D. Bomze; Vienna, AT

Thursday, September 7 / 08:30-09:30 / Hall 5

D11 Symposium: Limb Prostheses Chair 1 W. Mayr; Vienna, AT Chair 2 M. Bijak; Vienna, AT

08:30 IL Technical Design Considerations for Restauration of Prostheses based Movements W. Mayr; Vienna, AT

08:54 O11 Development of a modular bionic prototype arm prosthesis C. Kast; Vienna, AT

09:06 O12 A Preliminary Test of Online Learning FES Control by Feedback Error Learning Using Fuzzy Controller in Controlling Knee Extension Movement T. Watanabe; Sendai, JP

09:18 O13 Development process of prosthetic device for upper limb O. Canciglieri Junior; Curitiba, BR


PL1 Plenary Session 1 Chair E. Wolner; Vienna, AT

09:30 PL1 The future of Mechanical Cardiac Support J. Long; Oklahoma City, US

10:00 PL2 Development of Complex Air-way Tissue Models and their Biomedical Applications H. Walles; Würzburg, DE

ESAO-IFAO 2017 – Program Thursday, September 7 – Morning Session

22


A12 Heart & Pump: Modelling and Control Chair 1 E. Tatsumi; Osaka, JP Chair 2 L. Fresiello; Leuven, BE

11:00 O14 Venous physiology and cavopulmonary support in Fontan patients M. Granegger; Zurich, CH

11:15 O15 Exercise physiology with a VAD: study of left ventricular energetics with a computational model L. Fresiello; Leuven, BE

11:30 O16 In-Vitro Evaluation of Starling-like Control Based on Estimated Left Ventricular Stroke Work E. Wu; Brisbane, AU

11:45 O17 Stroke volume estimation and extreme membrane positions detection in pulsatile ventricular assist device. A. Siewnicka; Warsaw, PL

12:00 O18 Cardiac contractility index derived from pump flow during external rotary blood pump support: an in vitro study P. Naiyanetr; Nakorn Pathom, TH

12:15 O19 ECG-synchronized rotational speed change system has preventive effect on right heart failure during continuous-flow left ventricular assist device support. D. Akiyama; Suita, Osaka, JP


B12 Materials in Aphereses and Dialysis Chair 1 C. Legallais; Compiegne, FR Chair 2 L. Kramer; Vienna, AT

11:00 O20 Blood-Biomaterial Interactions in Extracorporeal Circulation. A. Campbell Ritchie; Nottingham, GB

11:12 O21 Mixed matrix membranes for outside-in dialysis O. ter Beek; Enschede, NL

11:24 O22 Mixed matrix membranes for the removal of endotoxins during hemodialysis I. Geremia; Enschede, NL

11:36 O23 Integrally skinned asymmetric cellulose acetate-silica membranes for extracorporeal blood ultrafiltration. M. Faria; Lisbon, PT

11:48 O24 Interpreting pore size values in membranes for renal replacement therapy A. Boschetti-de-Fierro; Hechingen, DE

12:00 O25 Biocompatible comparison in polysulfone membranes between polyvinylpyrrolidone and hydrophilic polymer coating for hemodialysis

K. Togo; Tokyo, JP 12:12 O26 Assessment of blood trauma due to

hematocrit variations in dialyzers F. Mouzakis; Aachen, DE


C12 Symposium: Tissue Regeneration (in cooperation with TERMIS)

Chair 1 N. Neves; Minho, PT Chair 2 T. Groth; Halle, DE

11:00 IL Soft-biomimetic environments to support cell organization and function J. Mano; Aveiro, PT

11:20 IL Biomimetic Materials for Cartilage Engineering M. Zenobi-Wong; Zuerich, CH

11:40 IL Engineering hydrogels to promote cell differentiation in soft tissue regeneration G. Gallego-Ferrer; Valencia, ES

12:00 IL Combining surface functionalized scaffolds with stem cells for advanced therapies N. Neves; Minho, PT

12:20 Discussion


D12 Symposium: New Aspects of Albumin (Albunet) Chair 1 J. Vienken; Usingen, DE Chair 2 U. Baurmeister; Wupperthal, DE

11:00 O27 The European ALBUNET network: Mission and Visions J. Vienken; Usingen, DE

11:10 O28 Analysis of albumin function by investigating conformational mobility K. Schnurr; Berlin, DE

11:30 O29 Non-invasive monitoring of bilirubin decrease in extracorporeal liver support patients M. Preussiger; Wuppertal, DE

11:50 O30 Extracorporeal liver support: Approaching the patient with liver failure B. Tyczynski; Essen, DE

12:10 O31 OPAL vs MARS:A case control study of two extracorporeal albumin dialysis techniques C. Wilms; Münster, DE

ESAO-IFAO 2017 - Program Thursday, September 7 – Afternoon Sessions

23

Program – Thursday Afternoon Thursday, September 7 / 12:45-13:45 / Hall 1

LS1 Lunch with Corporate Member Symposium: Optimizing Hemocompatibility - Opportunity and Challenge for Developers

Chair A. Menon; Berlin, DE

12:45 Peristaltic vs. Membrane Pumps in Purification Techniques – What's New? O. Favre; Geneva, CH

13:05 Optimizing hemocompatibility in VADs A. Wisniewski; Berlin, DE

13:25 Access to clean water – core for dialysis G. Grundström; Deerfield, US

Thursday, September 7 /14:00-15:30 / Hall 2

A13 Symposium: ICCAC-ESAO International VAD Coordinators

Chair 1 T. Schlöglhofer; Vienna, AT Chair 2 P. Combs; Oak Lawn, US

14:00 IL Blood pressure management in VAD patients: same limitations, new ideas? D. Robson; Sydney, AU

14:12 IL Why Did you Implant That Patient: The Vad Coordinator as Link between ICU and VAD Team H. Moody; Louisville, US

14:24 IL Vad Simulation for Staff Education - Practice Makes Perfect T. Elliott; Washington, US

14:36 IL Driveline Infections: Accept the challenge P. Combs; Oak Lawn, US

14:48 O32 Do LVAD patients need a specific diet to control weight ? K. Vandersmissen; Leuven, BE

15:00 IL Early Detection of Pump Thrombosis in VAD Patients T. Schlöglhofer; Vienna, AT

15:12 IL Caring for the pediatric VAD patient - they aren't just small adults J. Lantz; Dallas, US


B13 Symposium: Citrate Anticoagulation Chair 1 V. Weber; Krems, AT Chair 2 V. Witt; Vienna, AT

14:00 IL Regional citrate anticoagulation in continuous renal replacement therapy T. Slowinski; Berlin, DE

14:20 IL Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients L. Kramer; Vienna, AT

14:40 IL Citrate, use and proof of the use in pediatric apheresis V. Witt; Vienna, AT

15:00 O33 Influence of Citrate Concentration on Platelet Activation During Lipid Apheresis R. Weiss; Krems, AT

15:15 O34 Citrate Clearance of Current Dialysers: An In Vitro Study J. Hartmann; Krems, AT


C13 Tissue Engineering & Regenerative Medicine I Chair 1 H. Bergmeister; Vienna, AT Chair 2 T. Walles; Magdeburg, DE

14:00 IL Preliminary clinical results of the bioartificial TraVaSc Implant for airway reconstruction T. Walles; Magdeburg, DE

14:20 O35 3D-bioprinted capillary-like networks as versatile organ-on-a-chip platform A. Blaeser; Aachen, DE

14:32 O36 Tissue-engineered heart valve can change histological character after implantation Y. Takewa; Osaka, JP

14:44 O37 Reconstructing the blood vasculature within decellularized liver for generating a functional humanized organ K. Hussein; Chuncheon, KR

14:56 O38 Effect of porosity in freeze-dried decellularized porcine pulmonary heart valves on proteins and biomechanical properties A. Vásquez-Rivera; Hanover, DE

15:08 O39 Mid-term outcome of Cardiac Regenerative Therapy with Autologous Myoblast Cell Sheet Transplantation for Ischemic Cardiomyopathy K. Domae; Suita, Osaka, JP

15:20 Discussion

Thursday, September 7 / 14:00-15:30 / Hall 5 D13 Symposium: Cardiac Valves

Chair 1 B. Podesser; Vienna, AT Chair 2 K. Toda; Osaka, JP

14:00 IL Current topics and future perspectives of surgery for valve disease in Japan K. Toda; Osaka, JP

ESAO-IFAO 2017 – Program Thursday, September 7 – Afternoon Sessions

24

14:30 O40 In vitro calcification and mechanical loading on heart valves: development of new and improved model of in vivo processes D. Mavrilas; Patras, GR

14:40 O41 Functional Mitral Regurgitation Model in an Ex-Vivo Platform. M. Jaworek; Milano, IT

14:50 O42 In-vivo evaluation of ConVes a novel device for a sutureless aortic graft anastomosis S. Dual; Zürich, CH

15:00 O43 Development of an innovative design for a large-size percutaneous pulmonary valve prosthesis A. Gruenwald; Aachen, DE

15:10 Discussion

Thursday, September 7 / 15:30-16:30 Hallway – Level 8

PS1 Cardiac Assist Devices in Clinical Application I Chair 1 B. Biocina; Zagreb, HR Chair 2 B. Steinlechner; Vienna, AT

P1 Destination Therapy LVAD and Cancer: A case against Darwin’s Survival of the Fittest L. Samuels; Philadelphia, US

P2 Predictor for weaning from extracorporeal membrane oxygenation in infants with heart failure T. Goto; Hirosaki, JP

P3 The experience on technical supervision of patients supported by HVAD system R. Kustosz; Zabrze, PL

P4 Blood pressure control in heart failure patients supported by a centrifugal left ventricular assist device N. Reiss; Bad Rothenfelde, DE

P5 Effects of Ventricular Assist Device on cardiac troponin T isoform expression in pediatric patients with heart failure. R. Ragusa; Pisa, IT

P6 Outcomes of heart transplantation following support by MicroMed® DeBakey VAD® versus Heartware® HVAD® – A single center study. P. Angleitner; Vienna, AT

P7 Minimally invasive biventricular support with percutaneous extracorporeal membrane oxygenation and left ventricular assist system through mini-thoracotomy K. Domae; Suita City, Osaka, JP

P8 Mapping and ablation during mechanical circulatory support (BerlinHeart) in a child with diagnosed tachycardia-induced cardiomyopathy. Is this the way to wean? J. Śliwka; Zabrze, PL

Thursday, September 7 / 15:30-16:30

Hallway – Level 8

PS2 Cardiac Assist Devices in Clinical Application II Chair 1 P. Bonde; New Haven, US Chair 2 D. Wiedemann; Vienna, AT

P9 Cardiac rehabilitation of left ventricular assist device patients requiring renal replacement therapy - a major challenge N. Reiss; Bad Rothenfelde, DE

P10 The Experience of using ECMO on an infant after Modified Nikaidoh Procedure Q. Wu; Beijing, CN

P11 The usefulness of peripheral ECMO as a bridge to implantable LVAD in progressive decline heat failure patients H. Hata; Suita, Osaka, JP

P12 Clinical Course, Functional Capacity and Discontinuation of RVAD after Planned and Unplanned Biventricular Support System Implantation N. Reiss; Bad Rothenfelde, DE

P13 Short and long term left and right ventricular mechanics after LVAD implantation in pediatric patients: a 2D and 2D speckle tracking echocardiographic study R. Iacobelli; Rome, IT

P14 Do adults with a durable continuous-flow left ventricular assist device (LVAD) require an assigned caregiver on discharge? D. Robson; Sydney, AU

P15 International VAD Coordinator Practices: Clinical Utility and Application of HeartWare HVAD System Waveforms and Logfiles T. Schlöglhofer; Vienna, AT

P16 Development of a Suction Detection Algorithm from Patient Pump Data. M. Maw; Vienna, AT


Hallway – Level 8

PS3 Cardiac Assist Devices: Blood Trauma and Various Topics

Chair 1 J. Woodard; Berlin, DE Chair 2 S. Sonntag; Aachen, DE

P17 The Evaluation of Hemolysis in a Ventricular Assist Device-Preliminary study Y. Zhang; Beijing, CN

P18 Blood damage by handling: The crux of the matter L. Wiegmann; Zurich, CH


25

P19 Influence of the thrombus formation on the heat generation in the Sputnik RBP: In vitro studies A. Porfiryev; Moscow, RU

P20 Regurgitant flow in mechanical heart valves: fluid stresses and spatial correlation M. Grigioni; Rome, IT

P21 Oxidative stress increases susceptibility of red blood cells to shear-mediated damage A. McNamee; Gold Coast, AU

P22 Haemodilution Increases the Fragility of Red Blood Cells in Response to Mechanical Stress C. Robinson; Swansea, GB

P23 Erythrocyte tolerance to supra-physiological shear stress with exposure times reflective of clinical blood pumps J. Horobin; Gold Coast, AU

P24 Inductive energy transfer for personalized artificial organs A. Danilov; Moscow, RU

P25 Efficiency Measurement of Air-Core Transcutaneous Energy Transmission Systems for Ventricular Assist Devices Considering Common-Mode Currents for a Transformer Immersed in a NaCl Solution at a Transmission Frequency of 500 kHz T. Kaga; Katsushika, JP

P26 Transcutaneous energy transmission by capacitive coupling E. Drigo; Sao Paulo, BR

P27 Transcutaneous Energy Transmission using Capacitive Coupling for Cardiac Pacemaker: Calculation of AC-AC Energy Transmission Efficiency S. Kometani; Katsushika, JP

P28 Experimental and Numerical Analysis of Dye Washout in Ventricular Assist Devices A. Molteni; Swansea, GB


Hallway – Level 8

PS4 Dialysis/Apheresis - Experimental Approaches Chair 1 K. Matsuda; Yamanashi, JP Chair 2 J. Hartmann; Krems, AT

P29 Mathematic model of blood glucose dynamics K. Pozhar; Moscow, Zelenograd, RU

P30 Study of the effect of module geometry on forward filtration in hollow fiber dialyzers with a two-dimensional momentum transport model D. Donato; Hechingen, DE

P31 Modeling water transport across the cell membrane in HD patients M. Pietribiasi; Warsaw, PL

P32 Modified p(HEMA) cryogels as potential cell carriers for liver tissue engineering F. Bonalumi; Brighton, GB

P33 Sieving coefficients of hemodialysis membranes M. Hulko; Hechingen, DE

P34 Possible influence of hemodialysis on oxidative stress P. Dejanov; Skopje, MK

P35 Treatment of thrombotic microangiopathy with therapeutic plasma exchange using citrate anticoagulation B. Bizjak; Ljubljana, SI

P36 Citrate anticoagulation: Influence of haematocrit on the extraction ratio of citrate and urea K. Strobl; Kems, AT

P37 Influence of different anticoagulants on endotoxin activity in human serum S. Harm; Krems, AT

P38 Lipoprotein-associated phospholipase A2 Predicts Cardiovascular outcomes in peritoneal dialysis patients M. Li; Hangzhou, CN

P39 Challenge to a portable hemofiltration system in goat H. Sugawara; Chuoshi, JP

P40 Modeling of biotechnical system of artificial blood purification with wearable artificial kidney N. Zhilo; Moscow, Zelenograd, RU

P41 Trials of wearable artificial kidney SDR-01 N. Bazaev; Moscow, Zelenograd, RU

P42 Risk Factors and Outcomes of Early Peritonitis in Chinese Peritoneal Dialysis Patients Y. Tian; Hangzhou, CN

P43 Long-term outcome of patients with rapidly progressive glomerulonephritis requiring dialysis treated with plasmapheresis: a retrospective, single-centre study S. Kaixiang; Hangzhou, CN

Thursday , September 7 / 15:30-16:30

Hallway – Level 8

PS5 Biomaterials - Hydrogels - Scaffolds I Chair 1 K. Schneider; Vienna, AT Chair 2 A. Repanas; Halle, DE

P44 Modification and optimization of polysaccharides for hydrogel formation A. Repanas; Halle (Saale), DE

P45 Pegylated hydrogels as a novel drug delivery system against prostate cancer A. Repanas; Halle (Saale), DE


26

P46 Reversible Gelatin Hydrogels based on Semi-Covalent Interactions M. Vahedi; Tehran, IR

P47 Mechanical and in-vitro performance of porous hydroxyapatite/poly(lactic acid)/polycaprolactone composite scaffolds H. Ivanković; Zagreb, HR

P48 Oxygen permeability measurement of contact lenses: critical points G. D'Avenio; Rome, IT

P49 Vibrational spectroscopy of albumin and collagen as materials for creation of biostructures A. Polokhin; Moscow, Zelenograd, RU

P50 The Study of Zeta Potential of Gold Nanorods Based on the Electrophoretic Light Scattering Method S. Dolgushin; Zelenograd, Moscow, RU

P51 Investigation of the long-term visco-elastic mechanical properties of hernia meshes M. Doneva; Sofia, BG

P52 Two scientist, three results - What is the challenge in measuring Magnesium degradation? S. Knigge; Hanover, DE

P53 Haemocompatibility assessment of a-C:N:H nitrogen modified, amorphous hydrogenated carbon surface layers on polyether ether ketone M. Gonsior; Zabrze, PL

P54 Preparation of atorvastatin calcium loaded PLGA microspheres using solid-in-oil-in-water emulsion method R. Badiani; Tehran, IR

P55 Sustained drug delivery of Cyclosporine A (CyA) for extended treatment of dry eye syndrome F. Rafiei; Tehran, IR

P56 Influence of the degradation process on the release profile of idarubicin for the treatment of glioblastoma multiforme A. Borecka; Sosnowiec, PL


Hallway – Level 8

PS6 Biomaterials - Hydrogels - Scaffolds II Chair 1 P. Dungl; Vienna, AT Chair 2 M. Müller; Hanover, DE P57 A conceptual knowledge-based approach to

support dental implants planning A. Szejka; Curitiba, BR

P58 Requirements to elaborate new design of devices and accessories of ostomy pouching system O. Canciglieri Junior; Curitiba, BR

P59 Development for the driving mechanism of implantable artificial tongue T. Yambe; Sendai, JP

P60 Magnetically-controlled artificial urinary sphincters. T. Mazzocchi; Pontedera (PI), IT

P61 Research of inductive powering unit operation modes E. Mindubaev; Moscow, RU

P62 Laser fabrication of nanocarbone scaffolds in protein matrix for reconstruction cartilage and bone tissue A. Gerasimenko; Moscow, RU

P63 A new strontium and zinc doped bioglasses for tissue engineering B. Zagrajczuk; Krakow, PL

P64 Increasing of mechanical properties of artificial joint ligament by the bionanomaterials laser application method L. Ichkitidze; Moscow, Zelenograd, RU

P65 Small, smaller, smallest - A method to produce very small polymeric beads S. Knigge; Hanover, DE

P66 Numerical analysis of the PMMA-based cement flow in a trabecular structure of a vertebral K. Sobczak; Lodz, PL

P67 Electroactive poly(vinylidene fluoride) membranes with hydrophilic domains for osteogenic differentiation. G. Gallego-Ferrer; Valencia, ES

P68 Conducting Biocompatible Nanomaterial Layers L. Ichkitidze; Moscow, Zelenograd, RU

Thursday, September 7 / 15:30-16:30 Hallway – Level 8

PS7 Varia Chair 1 D. Rafolt; Vienna, AT Chair 2 W. Mayr; Vienna, AT

P69 Superconducting Film Concentrator in Ultraweak Magnetic Field Sensors L. Ichkitidze; Moscow, RU

P70 Capacitive-Coupling-based Information Transmission System for Implantable Esophageal pH Monitoring Sensor and Stimulator: Analysis of Receiving Voltage for Electrode Position Modification in Human Anatomical Model Y. Ishioka; Katsushika, JP

P71 Possibilities of using combined magnetic field sensors in magnetocardiography L. Ichkitidze; Moscow, Zelenograd, RU

P72 Flexible and Implantable Encapsulated Electrode for Measurement of Electrocardiogram K. Lee; Chuncheon, KR


27

P143 In memoriam Alex Medvedev, a career devoted to cardiac assist devices I. Medvedev; Ann Arbor, US


Hallway – Level 8

PS8 Valves Chair 1 A. Kocher; Vienna, AT Chair 2 Y. Takewa; Osaka, JP P73 Methods of tilting disc valves evaluation

P. Pydziński; Zabrze, PL P74 Polyurethane flexible valve for pulsatile

ventricular assist devices M. Gonsior; Zabrze, PL

P75 In vitro evaluation of a Styrene-based Polymeric Transcatheter Aortic Valve: The Effect of Leaflet Thickness on Hydrodynamic Function P. De Sciscio; Cambridge, GB

P76 In Vitro Modelling of Calcific Particles under Physiological Conditions: A Testbed for Cerebral Protection Devices (CPDs) C. Lierath; Aachen, DE

P77 Influence of the bulging sinus size and shape of the stimulated livesize EPTFE valve on the leaflet movement of the valve conduit T. Akutsu; Yokohama, JP


Hallway – Level 8

PS-L1 Late Abstract Poster Session I Chair 1 U. Losert Vienna, AT Chair 2 T. Verbelen Leuven, BE LP1 Investigation of the axial gap clearance in a

hydrodynamic-passive magnetically levitated rotary blood pump using X-ray radiography B. Thamsen; Zurich, CH

LP2 CFD study of a pulsatile ventricular assist device operating at high frequency C. Loosli; Zürich, CH

LP3 Performance and Efficiency of an Undulating Membrane Based Cardiac Assist Device P. Monticone; Paris, FR

LP4 Static and dynamic characterization of four rotary blood pumps S. Boës; Zurich, CH

LP5 The Effect of Pulsatility on Haemocompatibility Biomarkers of Rotary Blood Pumps J. Horobin; Gold Coast, AU

LP6 Application of soft robotics principles: a soft total artificial heart N. Cohrs; Zürich, CH

LP7 Requirements for outpatient care after implantation of a ventricular assist device – view of patients and their relatives T. Berg; Aachen, DE

LP8 “I can only sleep with the lights on now” – The different shades of psychological stress after critical illness A. Chan-Dominy; London, GB


A14 Experimental Models for Cardiovascular Devices

Chair 1 A. Khir; London, GB Chair 2 A. Molteni; Swansea, GB 16:30 O44 Mock Circulation for Ventricular Assist

Devices K. Affeld; Berlin, DE

16:45 O45 In vitro flow investigation in the aorta with two different compliances using stereo PIV I. Mueller; Aachen, DE

17:00 O46 Optimisation of Numerical Haemolysis Model to Enable Accurate Prediction of Haemolysis Performance in Ventricular Assist Devices A. Molteni; Swansea, GB

17:15 O47 The Anastomosis Angle of Outflow Graft to Aorta Influences on Hemodynamics of Aortic Valve Regurgitation in Left Ventricular Assist Device Support K. Iizuka; Osaka, JP

17:30 O48 Cardiac Flow Patterns during Mechanical Circulatory Support as a possible Link to Stroke Development P. Aigner; Vienna, AT

17:45 O49 Nitric oxide administration to the gas inflow of oxygenator improves cerebral perfusion and neuroprotection during ECMO. N. Ahmed; Verona, IT


B14 Challenges for Dialysis Devices Chair 1 R. Oberbauer; Vienna, AT Chair 2 S. Eloot; Ghent, BE 16:30 O50 Haemodialyser clotting: the inner counts.

F. Vanommeslaeghe; Ghent, BE 16:42 O51 Impact of Initial Dialysis Modality on the

Survival of Patients with ESRD: a Propensity-Matched Study X. Yao; Hangzhou, CN


28

16:54 O52 Mass-spectrometry based plasma proteomics to find the underlying molecular determinants of hypertension P. Gajjala; Aachen, DE

17:06 O53 Blood foam in the air trap during haemodialysis B. Stegmayr; Umea, SE

17:18 O54 Differentiation and heterogeneity of biomaterial-induced multinucleated giant cells: connection between inflammation and tissue regeneration M. Barbeck; Berlin, DE

17:30 O55 Cytokine Profiles In Sepsis Patients T. Eichhorn; Krems, AT

17:42 O56 The risk of catheter-related bloodstream infection with temporary femoral hemodialysis catheters V. Gerasimovska; Skopje, MK


C14 Symposium: Challenges in Vascular Tissue Engineering

Chair 1 B. Walpoth; Geneva, CH Chair 2 G. Faggian; Verona, IT 16:30 Vascular Tissue Engineering: "Quo Vadis?"

B. Walpoth; Geneva, CH 16:35 IL Cell-Assembled Extracellular Matrix (CAM)

for Vascular Applications N. L'Heureux; Bordeaux, FR

16:55 IL Decellularized human umbilical artery as a potential scaffold for long small diameter tissue engineered vascular grafts A. Mishanin; St. Petersubrg, RU

17:10 O57 S-Nitroso Human Serum Albumin Releasing Poly(ε-Caprolactone) Small Diameter Vascular Graft M. Enayati; Vienna, AT

17:20 O58 Neointima inducing process on small-diameter decellularized vascular graft modified with the bioactive peptide A. Mahara; Osaka, JP

17:30 O59 Decellularized small diameter vascular grafts from the human placenta: Assessment of the functional performance in a rat model K. Schneider; Vienna, AT

17:40 O60 Application of the xenogeneic decellularized tube matrix produced by in vivo tissue engineering to the 'off-the-shelf' small-caliber vascular graft M. Yamanami; Kyoto, JP

17:50 Discussion


D14 Symposium: Numerical Modeling in Hemodialysis

Chair 1 A. Remuzzi; Bergamo, IT Chair 2 A. Dimasi; Milano, IT 16:30 O124 Effect of double-filtration plasmapheresis

for antibody-mediated rejection regarding coagulation parameters and thrombin generation L. Rostaing; Grenoble, FR

16:45 O61 Towards longitudinal analysis of arteriovenous fistula for hemodialysis using contrast-free magnetic resonance angiography M. Bozzetto; Ranica (BG), IT

16:55 O62 An experimental setup to study the occurrence of perivascular vibrations in arteriovenous vascular access U. Krueger; Berlin, DE

17:05 O63 Numerical hemodynamic simulations for monitoring of vascular patients J. Carroll; Sydney, AU

17:15 O64 Modelling of cardiovascular alterations during CKD progression G. Casagrande; Milan, IT

17:25 O65 Bayesian Identification of Patient-Specific Parameters in a Dialysis Kinetic Model C. Bianchi; Milano, IT

17:35 O66 Cardiovascular response to haemodialysis – a new integrated mathematical model L. Pstras; Warsaw, PL

17:45 IL Vascular access in hemodialysis patients: from numerical modeling to vascular biology A. Remuzzi; Bergamo, IT

ESAO-IFAO 2017 - Program Friday, September 8 – Morning Sessions

29

Program – Friday Morning

A21 Heart Regeneration and Transplantation Chair 1 A. Zuckermann; Vienna, AT Chair 2 S. Jacobs; Leuven, BE 08:30 O67 Characterization of miRNA expression in

cardiac isograft vasculopathy using a heterotopic abdominal mouse heart transplantation model A. Schaefer; Vienna, AT

08:42 O68 Remote ischemic postconditioning improves post-ischemic cardiac function:the role of Neuregulin-1 P. Pilz; Vienna, AT

08:54 O69 A morpho-biomechanical perspective on heart remodeling after MI M. Rusu; Aachen, DE

09:06 O70 The OCS HEART system for ex vivo perfusion of the donor heart: A step toward future? l. Botta; Milano, IT

09:18 O71 Comparing different unloading strategies in an ovine model of post-infarction heart failure. S. Jacobs; Leuven, BE

Friday, September 8 / 08:30-09:30 / Hall 4

B21 Symposium: Extracellular Vesicles Chair 1 B. Stegmayr; Umea, SE Chair 2 C. Tripisciano; Krems, AT 08:30 IL Blood purification may interfere with

microvesicles in blood B. Stegmayr; Umea, SE

08:40 O72 Characterization of Extracellular Vesicles in Whole Blood: Influence of Preanalytical Parameters B. Fendl; Krems, AT

08:50 IL Extracellular Vesicles- from Discovery to Clinical Application A. Reiner; Vienna, AT

09:10 IL Role of Phosphatidylserine and Tissue Factor in Supporting Extracellular Vesicles Induced Thrombin Generation C. Tripisciano; Krems, AT

09:20 Discussion


C21 Biomaterials II: Soft Tissue Replacement Chair 1 B. Glasmacher; Hanover, DE Chair 2 D. Mavrilas; Patras, Greece 08:30 O73 The investigation of the influence of the

laser solder composition on the welds tensile strength D. Ryabkin; Zelenograd, RU

08:40 O74 Investigation of bendability and anisotropy of fiber-based vascular grafts under physiological conditions M. Bode; Hanover, DE

08:50 O75 The anticalcification potential of Heparin on hydroxyapatite seed crystals A. Badria; Rion-Patras, GR

09:00 O76 The application of poly(L-lactide-co-glycolide-co-trimethylene carbonate) to formulate rods with 17-β-estradiol A. Turek; Sosnowiec, PL

09:10 O77 Enhanced Interfacial Bonding Strength of Hydrophobically-modified, Alaska pollock Gelatin-based Surgical Sealants T. Taguchi; Tsukuba, JP

09:20 O78 Long-term urine-resistant artificial bladder T. Mazzocchi; Pontedera (PI), IT


D21 Blood Trauma Chair 1 K. Affeld; Berlin, DE Chair 2 M. Trivella; Pisa, IT 08:30 O79 Assessment of leukocyte functionality in

contact with a foreign surface under shear stress G. Radley; Swansea, GB

08:42 O80 Shear stress exposure alters the electrochemical and physical properties of erythrocytes A. McNamee; Gold Coast, AU

08:54 O81 Numerical Comparison of Shear and Elongational Stresses in Rotary Ventricular Assist Devices D. Khoo; Bath, GB

09:06 O82 Ovine activated leukocyte microparticles generated by the CentriMag ventricular assist device in vitro I. Pieper; Swansea, GB

09:18 O83 Evaluation of hemocompatibility of a hydrodynamically levitated centrifugal blood pump using hyperspectral imaging in acute animal studies R. Kosaka; Tsukuba, JP


ESAO-IFAO 2017 – Program Friday, September 8 – Morning Sessions

30


PL2 Plenary Session 2 Chair K. Dasse; Louisville, US

09:30 PL3 The Bionic Hand: Coupling the Brain to Prostheses O. Aszmann; Vienna, AT

10:00 PL4 Mechanical Cardiac Support and Cardiac Rhythm Management: A Marriage of two Technologies M. Hess; Minneapolis, US


A22 Symposium: Numerical Modelling: Design, Optimization and Functional Characterization of VAD's

Chair 1 F. Consolo; Milan, IT Chair 2 L. Wiegmann; Zürich, CH 11:00 O84 Past and Future of Blood Damage

Modelling in Biofluid Mechanics Laboratory L. Goubergrits; Berlin, DE

11:12 O85 Strain-Based Blood Damage Modeling – Current Status and Future Perspectives L. Pauli; Aachen, DE

11:24 O86 Computational fluid dynamic analyses and in vitro assessment of a novel microfluidic flow-based assay A. Dimasi; Milano, IT

11:36 O87 Numerical modeling of the thrombogenic potential of altered hemodynamics at the left ventricular apex-LVAD interface based on non-invasive patient-specific imaging techniques F. Consolo; Milano, IT

11:48 O88 Numerical design improvement and experimental testing of a small VAD K. Fraser; Bath, GB

12:00 O89 Influence of pump design variations on hydraulic performance and blood damage: a computational fluid dynamics analysis L. Wiegmann; Zurich, CH

12:12 O90 Robust computational tools to improve the development process of mechanical circulatory support T. Kaufmann; Aachen, DE

12:24 Summary


B22 Emerging Applications in Extracorporeal Therapies

Chair 1 K. Derfler; Vienna, AT Chair 2 Y. Wu; Seattle, US 11:00 IL Lp(a), a risk factor for cardiovascular

disease a successful treatment with LDL apheresis K. Derfler; Vienna, AT

11:30 IL Extracorporeal therapies in the stem cell transplantation setting V. Witt; Vienna, AT

11:50 IL Selective apheresis of C-reactive protein: a new treatment option for myocardial infarction, stroke, pancreatitis, Crohn's disease, after bypass surgery and rheumatic diseases A. Sheriff; Berlin, DE

12:10 IL CytoSorb in liver failure B. Tyczynski; Essen, DE


C22 Symposium: Nanomedicine Chair 1 T. Groth; Halle, GE Chair 2 G. Gallego-Ferrer; Valencia, ES 11:00 IL Two Decades of Commercializing

Nanomedicine for Artificial Organs T. Webster; Boston, US

11:25 IL 3D Printing of Advanced Photopolymers in Tissue Engineering S. Baudis; Vienna, AT

11:45 O91 Immobilization strategies with glycosaminoglycans-polymeric drug conjugate on biomaterials for anti-inflammatory purposes H. Al-Khoury; Halle (Saale), DE

12:00 O92 Electrospinning of fibres for nanomedical applications A. Repanas; Halle (Saale), DE

12:15 O93 Vascular grafts with defined fiber orientations C. Grasl; Vienna, AT

ESAO-IFAO 2017 - Program Friday, September 8 – Morning Sessions

31


D22 Symposium: Regulatory Affairs Chair 1 H. Schima; Vienna, AT Chair 2 Y. Taenaka; Osaka, JP 11:00 IL The new EU Medical Device Regulation

J. Vienken; Usingen, DE 11:20 O94 Impact of New European MEDICAL DEVICE

REGULATION (MDR) on Artificial Organs Regulatory Approval U. Wallstab; Overath, DE

11:32 O95 Clinical evaluation of artificial organs regulated as medical device U. Wallstab; Overath, DE

11:44 O96 3D printed medical devices under the perspective of EU regulation M. Grigioni; Rome, IT

11:56 O97 Current Status of the Redemption Price of the Medical Devices in Japanese Insurance System during 2015-2016 E. Akagawa; Suita, JP

12:08 O98 Nanostructured medical devices: the need for a specific roadmap of the regulatory framework M. Grigioni; Rome, IT

12:20 Discussion

ESAO-IFAO 2017 – Program Friday, September 8 – Afternoon Sessions

32

Program – Friday Afternoon


PL5 Lunch with Plenary Lecture 5 Chair S. Ash; Lafayette, US

12:30 PL5 Dialysis: From an Awkward, Complicated Method to a Mass Therapy and Beyond E. Leonard; New York, US


A23 Symposium: Blood Damage in Rotary Assist Devices

Chair 1 U. Kertzscher; Berlin, DE Chair 2 M. Kameneva; Pittsburgh, USA 13:30 Blood trauma in rotary blood pumps, an

introduction U. Kertzscher; Berlin, DE

13:35 IL Advanced Surface Properties to Mitigate Hemolysis and Thrombosis M. Kameneva; Pittsburgh, US

13:50 O99 Visualized erythrocyte’s shear induced damage process under high shear flow N. Watanabe; Saitama-City, JP

14:02 O100 Red blood cell responses to shear stress exposure in patients un/likely to receive mechanical circulatory support M. Simmonds; Gold Coast, AU

14:14 O101 Investigation of Shear-Induced Platelet Damage with a Couette Shear Device M. Lommel; Berlin, DE

14:26 O102 Von Willebrand Factor and a Correlation to Turbulence K. Affeld; Berlin, DE

14:38 O103 Can we predict the thrombotic risk in patients with Left Ventricular Assist Devices? F. Consolo; Milano, IT

14:50 O104 Influence of dynamically changing operating conditions on the hemocompatibilty of rotary blood pumps B. Thamsen; Zurich, CH

15:02 O105 A modified Chandler-Loop as a benchmark for hemodynamic simulation studies. S. Engel; Hanover, DE

15:14 Panel Discussion


B23 Symposium: Dialysis of Today and Tomorrow Chair 1 B. Stegmayr; Umea, SE Chair 2 B. Lindholm; Stockholm, SE 13:30 Introduction: Different survival on dialysis

in USA, Europe and Japan B. Stegmayr; Umea, SE

13:35 IL Japanese strategies of dialysis today and tomorrow K. Matsuda; Tokyo, JP

14:00 O106 Carbon Block Column (CB) for Regeneration of Dialysate in CVVHD S. Ash; Lafayette, Indiana, US

14:25 IL Large uremic toxins: clinical relevance and strategies for remova S. Eloot; Ghent, BE

14:37 IL Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration J. Jankowski; Aachen, DE

14:49 IL (Bio)artificial kidney systems for improved blood purification D. Stamatialis; Twente, NL

15:01 IL Peritoneal dialysis for urgent dialysis initiation B. Lindholm; Stockholm, SE

15:13 Discussion


C23 Tissue Engineering & Regenerative Medicine II Chair 1 C. Radtke; Vienna, AT Chair 2 H. Redl; Vienna, AT 13:30 IL TERM in the Austrian Cluster for Tissue

Regeneration H. Redl; Vienna, AT

14:00 O107 An influence of the zinc oxide nanoparticles on properties of the endothelial cells cultured under physiological flow A. Ciechanowska; Warsaw, PL

14:12 O108 Material-driven assembly of fibronectin (nano)networks in 2D substrates and 3D scaffolds: effect of chemical crosslinking on fibronectin organization R. Sabater i Serra; València, ES

14:24 O109 Microspheroid Assemblies : Levitating PCL –IO Spheroids in Biomaterial Applications – Insights from Respirometry F. Fernandez; Trivandrum, IN

ESAO-IFAO 2017 - Program Friday, September 8 – Afternoon Sessions

33

14:36 O110 Human induced pluripotent stem cells-based strategies for bone tissue engineering and regeneration. D. Marolt Presen; Vienna, AT

14:48 O111 Osteogenic differentiation of human mesenchymal stem cells under physiological fluid shear stress C. Kasper; Vienna, AT


D23 Symposium: Artificial Lung Chair 1 D. Mottaghy; Aachen, DE Chair 2 R. Ullrich; Vienna, AT

13:30 IL Extracorporeal support for the lungs: from research to clinics – from rescue to ethics M. Quintel; Göttingen, DE

14:00 O112 Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Membrane Contactor M. Harasek; Vienna, AT

14:15 O113 In Vitro Characterization of the Pittsburgh Pediatric Ambulatory Lung Device R. Orizondo; Pittsburgh, US

14:30 O114 RAS-Q – A Novel Passive Right Heart Assist System T. Kaufmann; Aachen, DE

14:45 O115 Controlled Blood Recirculation Enhances Oxygenation Efficiency in an Artificial Lung S. P. Madhani; Pittsburgh, US

15:00 O116 Investigations of Thrombus Distribution After Long Term ECMO and Blood Flow Distribution Using CFD in An Oxygenator N. Katagiri; Suita, Osaka, JP

15:15 O117 In-Vitro and In-Vivo Studies of an Integrated, Wearable Blood Pump-Lung S. Madhani; Pittsburgh, US

Friday, September 8 / 15:30-16:30

Hallway – Level 8

PS9 Pump Development Chair 1 A. Andrade; Sao Paulo, BR Chair 2 M. Granegger; Zurich, CH P78 Long-term use Assessment of the Apico-Aortic

Blood Pump: Durability and wear assessment B. Utiyama; Sao Paulo, BR

P79 Transventricular Assist Device (TVAD) – In Vitro evaluation of a new axial blood pump using polymeric valve for rotational speed reduction A. Andrade; Sao Paulo, BR

P80 Precision matching pulsatile blood pump M. Yang; Shaghai, CN

P81 Total artificial heart (TAH): preliminary results in vitro D. Galantini; São Paulo, BR

P82 Methodology for the Application of Risk Analysis to Improve the Reliability of Ventricular Assit Device J. Dias; São Paulo, BR

P83 Remote Monitoring of Russian VAD system AVK-N G. Itkin; Moscow, RU

P84 Tele-care and tele-rehabilitation model for VAD patient’s treatment R. Kustosz; Zabrze, PL

P85 Integration of Ultrasonic Flow Measurement in Cardiac Support Systems E. Huber; Finning, DE

P86 Design of a Smart System for a Ventricular Assist Device M. Barboza; São Paulo, BR

P87 Preliminary results of In Vitro endothelialization on plasma modified titanium surface E. Drigo; São Paulo, BR

P88 Design optimization and in vitro and in vivo verification of CorWave disk membrane LVAD P. Monticone; Paris, FR


Hallway – Level 8

PS10 Experimental and Numerical Modelling Chair 1 A. Di Molfetta; Rome, IT Chair 2 F. Moscato; Vienna, AT P89 In-vitro Measurement of Centering Forces on a

Transvalvular Ventricular Assist Device Cannula M. Stoiber; Vienna, AT

P90 Blood viscosity investigation to define best numerical and in vitro test values to benchmark VAD performance C. Moriarty; Swansea, GB

P91 Quantitative assessment of heart-pump interaction for an axial-flow rotary blood pump Sputnik: in vitro study D. Petukhov; Zelenograd, RU

P92 Development of Frank-Starling mechanical mock circulatory loop for rotary blood pump testing T. Khienwad; Nakhon Pathom, TH

P93 Modelling the impact of hypertension on continuous flow left ventricular assist device function C. Hayward; Sydney, AU

P94 Computerized closed-loop propofol anaesthesia in cardiac surgery. V. Magilevets; Moscow, RU


34

P95 Virtual patient in studies of ventilation capacity improvement by LVAD support in congestive heart failure K. Zielinski; Warsaw, PL

P96 Fluid dynamical study of the univentricular patient: the case of HLHS G. D'Avenio; Rome, IT

P97 Minimal model of cardiovascular system assisted by a veno-arterial extracorporeal membrane oxygenation S. Habran; Liege, BE

P98 Evaluation of a hybrid cardiovascular simulator J. Fonseca; Sao Paulo, BR

P99 Measurements of pressure drop in arteriovenous fistula models - in vitro investigations D. Jodko; Lodz, PL

P100 Numerical Simulation of the HeartMate 3 M. Nicolai; Berlin, DE

P101 Can Simulation Become a Preoperative Planning Approach in Patients Requiring Mechanical Circulatory Support? M. Capoccia; Leicester, GB

Friday, September 8 / 15:30-16:30 Hallway – Level 8

PS11 Artificial Lung and Respiratory Support Chair 1 R. Ullrich; Vienna, AT Chair 2 S. Madhani; Pittsburgh, US

P102 Effects of Hollow Fiber Oscillation on Artificial Lungs R. Orizondo; Pittsburgh, US

P103 Multiobjective Design Optimization of Endothelializable Oxygenator Membranes Using Computational Fluid Dynamics F. Hesselmann; Aachen, DE

P104 Experimental Flow Visualization and Wall Shear Stress Measurements in an Endothelializable Membrane Oxygenator Using Particle Tracking Velocimetry F. Hesselmann; Aachen, DE

P105 Oxygen Mass Transfer in a Surrogate System of Membrane Blood Oxygenators C. Moreira; Lisbon, PT

P106 Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Drive Unit and Control System M. Gföhler; Vienna, AT

P107 The use of an artificial patient in analysis of possible causes of changes in arterial blood gases during therapeutic thoracentesis A. Stecka; Warsaw, PL

P108 In-vivo study of a novel lung support device for PAH and bridge-to-transplant/candidacy T. Verbelen; Aachen, DE


Hallway – Level 8

PS12 Dialysis/Apheresis - Clinical Chair 1 G. Böhmig; Vienna, AT Chair 2 V. Witt; Vienna, AT P109 Therapeutic apheresis in severe Guillain-Barre

syndrome – our experience from 2009 to 2017 A. Marn Pernat; Ljubljana, SI

P110 Immunology Absorption induces remission in ANCA-associated vasculitis X. Lei; Hangzhou, CN

P111 Changes of subjective global assessment is associated with clinical outcomes of peritoneal dialysis patients X. Yan; Hangzhou, CN

P112 Relationship between serum uric acid and all-cause mortality in maintenance hemodialysis patients L. Zhang; Hangzhou, CN

P113 Association between medical insurance type and survival in hemodialysis patients in China X. Yao; Hangzhou, CN

P114 Epidemiological Survey of Incident End Stage Renal Disease Patients from 2010 to 2014 in Zhejiang Province, China W. Lei; Hangzhou, CN

P115 Genome-wide analysis of DNA methylation and gene expression characteristics of dialysate-induced peritoneal fibrosis P. Yan; Hangzhou, CN

P116 Tamoxifen attenuates PDF-induced peritoneal fibrosis via reducing GSK3β/β-catenin axis activation P. Yan; Hangzhou, CN


Hallway – Level 8

PS13 Tissue Engineering and Organ Regeneration I Chair 1 B. Kapeller; Vienna, AT Chair 2 S. Baudis; Vienna, AT P117 An in vitro skin wound infection model and

bioevaluation of antimicrobial wound dressings A. Idrees; Bochum, DE

P118 Development of Tissue-Engineered Cardiac Patch based on Silk Fibroin Y. Nakazawa; Tokyo, JP


35

P119 Microparticles from decellularized human liver tissue for increasing the biocompatibility of artificial grafts M. Bobrova; Moscow, RU

P120 Tissue engineering as a way for working out a bioartificial liver support at the treatment of chronic liver failure M. Shagidulin; Moscow, RU

P121 Preparation of Decellularized Porcine Renal Scaffolds for Potential Xenotransplantation: Technique and Biocompatibility Evaluation K. Hussein; Chuncheon, KR

P122 Extract of cryopreserved piglets heart fragments as regulating agent proceeding of experimental myocardial necrosis L. Rohoza; Kharkiv, UA

P123 Characterization of the functionalized biodegradable collagen scaffolds for in vivo delivery of SDF-1α and substances with bactericidal activity I. Pokholenko; Kyiv, UA

P124 Genetically modified human hepatoma and feeder layer cells for bioartificial liver devices A. Samluk; Warsaw, PL


Hallway – Level 8

PS14 Tissue Engineering and Organ Regeneration II Chair 1 M. Zenobi-Wong; Zuerich, CH Chair 2 S. Nürnberger; Vienna, AT P125 Development of an in-situ transfection system for

regeneration of bone Y. Brito Barrera; Halle (Saale), DE

P126 Studies on osteogenic differentiation of cells on multilayers loaded with BMP-2 R. Anouz; Halle (Saale), DE

P127 Effect of pO2 on viability and staging of bovine follicles cultured in vitro in dishes in strips of ovarian cortical tissue G. Catapano; Rende, IT

P128 Mathematical modeling and experimental procedures for tissue engineering of blood vessels by electrospinning M. Zivanovic; Kragujevac, RS

P129 A Datamining Approach for Anatomic Skull Prosthesis Modelling Optimization O. Canciglieri Junior; Curitiba, BR

P130 Effect of non-uniform construct permeability on matter distribution in radial flow packed bed bioreactors (rPBBs) for bone tissue engineering (BTE) G. Falvo D'Urso Labate; Rende, IT

P131 Non-contact Measurement of Dielectric Properties of Biological Tissues using Magnetic Induction at 500 kHz S. Kawai; Katsushika, JP

P132 Controlled infiltration of cells into electrospun scaffolds fabricated for application in small diameter vascular grafts S. Suresh; Hanover, DE


Hallway – Level 8

PS15 Tissue Engineering and Regenerative Medicine Chair 1 V. Weber; Krems, AT Chair 2 H. Schima; Vienna, AT

P133 Poly(L-lactic acid) microspheres induce “in vivo” articular cartilage regeneration in rabbits M. Sancho-Tello; Valencia, ES

P134 Silk fibroin/collagen films for rat skin wound regeneration L. Safonova; Moscow, RU

P135 3D porous polycaprolactone scaffolds for cartilage regeneration M. Sancho-Tello Valls; Valencia, ES

P136 Force induced piezoelectric effect of PVDF and PVDF-TrFE scaffolds F. Al Halabi; Hanover, DE

P137 Poly(L-lactic acid) (PLLA) mats for human airway mucosa regeneration M. Sancho-Tello Valls; Valencia, ES

P138 Does excess gravity affect cell deformation and orientation after stimulation? S. Hashimoto; Tokyo, JP

P139 Measurement of Contraction of Myotube on Scaffold Film with Micro-markers by Electric Stimulation S. Hashimoto; Tokyo, JP

P140 Effect of the co-application of Matriderm and mesenchymal stem cells on wound healing I. Lang; Graz, AT

P141 Spheroid-based 3D culture model with PC12 cells for application of neuronal stimulation electrodes S. Lee; Cheonju-si, Chungbuk, KR

P142 Myoblast migrates under controlled wall shear stress field in vitro S. Hashimoto; Tokyo, JP


36


Hallway – Level 8

PS-L2 Late Abstract Poster Session II Chair 1 R. Ponikvar; Ljubljana, SI Chair 2 E. Leonard; New York, US

LP9 In Vitro Testing of an Integrated, Low Flow Extracorporeal CO2 Removal Device A. May; Pittsburgh, US

LP10 Application of oxygen micro/nano bubble dispersions for total liquid ventilation H. Sato; Shinjuku, JP

LP11 A capillary membrane oxygenator with integrated pump function for organ transplant perfusion. F. Mouzakis; Aachen, DE

LP12 Removal capability of CytoSorb hemadsorption columns for selected drugs frequently used for deliberate drug overdose A. Koertge; Rostock, DE

LP13 In Vitro Investigations of Membrane Permeabilities of Various Hemofilters T. Wild; Rostock, DE

LP14 A single venesection improves the mechanical properties of blood in patients with haemochromatosis K. Richardson; Gold Coast, AU

LP15 Effect of venous stenosis on flow resistance: A fluid dynamic model F. Mouzakis; Aachen, DE

LP16 Tissue-engineered skeletal muscle and its application to actuator with long-term drivability T. Fujisato; Osaka, JP


A24 Computational Fluid Dynamics I Chair 1 T. Kaufmann; Aachen, DE Chair 2 S. Hashimoto; Tokyo, JP 16:30 O118 Evaluation of Numerical Models in

Simulation of Intraventricular Flow Pattern with Left Ventricular Assist Device Support M. Ghodrati; Vienna, AT

16:45 O119 The effect of inflow cannula insertion lengths on the risk of ventricular thrombosis in a multiscale numerical model S. Liao; Chermside, AU

17:00 O120 Comparison of an Unsteady-Reynolds-Averaged and a Very-Large-Eddy Simulation regarding their Potential to Predict Hemolysis with Stress-Based Hemolysis Models L. Konnigk; Rostock, DE

17:15 O121 Numerical modelling of leukocyte deformation in Ventricular Assist Devices K. Fraser; Bath, GB

17:30 O122 An extensive comparison of power-law-based hemolysis models for the blood pump of the FDA’s Critical path challenge. S. Engel; Magdeburg, DE

17:45 O123 Development of Prediction Methods of Shear induced Thrombus Formation by CFD Method including Concentration Transport and Aggregation Process and by Thrombus Visualization Method M. Tamagawa; Kitakyushu, JP


B24 Transplantation Related Aspects of Dialysis Chair 1 J. Winters; Rochester, US Chair 2 C. Aufricht; Vienna, AT 16:30 IL Apheresis in Renal Transplantation

G. Böhmig; Vienna, AT 16:55 IL New Aspects in Pediatric

RenalTransplantation K. Heindl-Rusai, Vienna, AT

17:10 O125 Efficacy and Safety of Cinacalcet Therapy for Renal Transplant Patients with Secondary Hyperparathyroidism—A Systematic Review and Meta-Analysis Y. Lu; Hangzhou, CN

17:25 O126 Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients L. Qu; Hangzhou, CN

17:40 Discussion


C24 "Bioartificial Organs" Working Group Chair 1 D. Stamatialis; Twente, NL Chair 2 C. Legallais; Compiegne, FR 16:30 IL Novel membrane systems for pancreatic

cell encapsulation D. Stamatialis; Twente, NL

16:50 IL Advances in cell microencapsulation for bioartificial liver C. Legallais; Compiegne, FR

17:05 IL Can we bioengineer functional kidney tissue? R. Masereeuw; Utrecht, NL

17:20 IL Achievements and hurdles of kidney bioengineering A. Remuzzi; Bergamo, IT


37

17:35 IL Engineering blood and lymphatic vascular beds W. Holnthoner; Vienna, AT

17:50 Discussion


D24 Clinical Reports and Exercise Chair 1 G. Wieselthaler; San Francisco, US Chair 2 G. Ferrari; Rome, IT 16:30 O127 Acute and Long-term effects of LVAD

support on right ventricular function in children with pediatric pulsatile ventricular assist devices R. Iacobelli; Rome, IT

16:45 O128 Short and Long Term Changes in Ventricular Loading Condition in LVAD patients: pulsatile vs continuous flow LVAD A. Di Molfetta; Rome, IT

17:00 O129 Do LVADs provide sufficient cardiac support during physical exercise when driven at constant speed? C. Gross; Vienna, AT

17:15 O130 Exercise capacity in VAD and heart transplanted patients: a comparative study L. Fresiello; Leuven, BE

17:30 O131 The Clinical Results, Adverse Events, and Change of End-organ Function in Elderly Patients with HeartMateII LVAD ~Japanese Multicenter Study~ D. Yoshioka; Suita, JP

17:45 O132 Viennese experience with the HeartMate III Left Ventricular Assist Device K. Dimitrov; Vienna, AT


GA ESAO General Assembly Chair 1 T. Groth; Halle, GE Chair 2 S. Eloot; Ghent, BE 18:00 only for members

ESAO-IFAO 2017 – Program Saturday, September 9 – Morning Sessions

38

Program – Saturday Saturday, September 9 / 08:30-09:30 / Hall 2

A31 Computational Fluid Dynamics II Chair 1 L. Goubergrits; Berlin, DE Chair 2 J.R. Stanfield; Salt Lake City, US 08:30 O133 Fluid-Structure Interaction (FSI)

Hemodynamic Optimization of CorWave Endovascular Cardiac Assist Device F. Cornat; Paris, FR

08:40 O134 Rotordynamic analysis of an artificial axial-flow cardiac-pump using Bond-graph methodology J. Kumar; Rostock, DE

08:50 O135 A novel generic model for the investigation of intraventricular flow patterns in individual hearts K. Hugenroth; Aachen, DE

09:00 O136 CFD modeling of IABP-induced abdominal occlusions and statistical analysis of effects on hemodynamics G. Fragomeni; Catanzaro, IT

09:10 O137 Effect of inflow cannulas side-hole number on drainage flow characteristics: flow dynamic analysis using numerical simulation T. Goto; Hirosaki, JP

09:20 O138 Modeling Maturation of Patient-Specific Arteriovenous Fistula's Using Computational Fluid Dynamics E. Colley; Sydney, AU

Saturday, September 9 / 08:30-09:30 / Hall 4

B31 Uremic Toxins I: EUTOX Symposium Chair 1 J. Jankowski; Aachen, DE Chair 2 G. Cohen; Vienna, AT 08:30 IL Intra-dialyser Transmembrane and

Hydrostatic pressures and convection: Measurement pitfalls and relevance À. Argilés; Montpellier, FR

08:50 IL Bubbling the extra-corporeal circuits: where the bubbles come from, are they harmful and can we prevent their appearance? B. Stegmayr; Umea, SE

09:10 IL Protein – bound toxins: Increased release results in increased removal J. Jankowski; Aachen, DE


C31 Tissue Engineering & Regenerative Medicine III

Chair 1 C. Kasper; Vienna, AT Chair 2 H. Bergmeister; Vienna, AT 08:30 O139 Fabrication of Proanthocyanidin cross-

linked Chitosan-Gelatin hydrogel scaffolds for tissue engineering A. Encerrado Flores; Nottingham, GB

08:42 O140 Fabrication of porous poly(trimethylene carbonate) membranes for lungs-on-chips T. Pasman; Enschede, NL

08:54 O141 Rapamycin Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelium Cells through Regulation of RhoGTPases X. Shilong; Hang Zhou,Zhe Jiang, CN

09:06 O142 Decellularized Liver Extracellular Matrix Gel Promotes Resolution of Liver Fibrosis in Mice K. Hussein; Chuncheon, KR

09:18 O143 Towards a fully implantable autonomous artificial pancreas V. Iacovacci; Pontedera, IT


D31 Symposium: 3D Additive Manufacturing / Biofabrication

Chair 1 J. Jacak; Linz, AT Chair 2 F. Moscato; Vienna, AT 08:30 IL Nanostructuring and nanoscopy in 3D

J. Jacak; Linz, AT 08:45 IL Application of indirect optical

micromanipulation in fluorescent, 3D live cell imaging L. Kelemen; Szeged, HU

09:00 IL Generation of photo-induced microstructures on biomaterial surfaces for control of cell attachment. J. Heitz; Linz, AT

09:15 IL Open-source 3D biofabrication platform for specialized scientific and industrial solutions B. Vihar; Maribor, SI

ESAO-IFAO 2017 Saturday, September 9 – Morning Sessions

39


PL3 Plenary Session 3 Chair 1 B. Meyns; Leuven, BE Chair 2 J. Jankowski; Aachen, DE 09:30 PL6 Apheresis for Dilated Cardiomyopathy

J. Winters; Rochester, US 10:00 PL7 Medical device innovation in Asia and

Japan - Present and future strategy Y. Taenaka; Osaka, JP


A32 Symposium: Challenges in Tailoring a Rehabilitation Program

Chair 1 C. Marko; Vienna, AT Chair 2 T. Elliott; Washington DC, US 11:00 IL How to set up a rehabilitation program for

patients with VADs: Experiences in Austria C. Marko, Vienna, AT

11:25 IL Can rehabilitation prevent LVAD related complications? C. Hayward; Sydney, AU

11:45 IL Hot topics in the long term psycho-social care C. Kugler; Freiburg, DE

12:05 Panel Discussion


B32 Uremic Toxins II Chair 1 À. Argilés; Montpellier, FR Chair 2 J. Hua; Hangzhou, CN 11:00 O144 Exploring protein binding of different

uraemic toxins O. Deltombe; Ghent, BE

11:12 O145 Modelling uremic toxicity: further steps towards a precise in vitro detection of toxic effects caused by uremic retention solutes T. Vollmer; Berlin, DE

11:24 O146 Not creatinine but protein-bound uraemic toxins are predominant in the prediction of QoL in children with CKD E. Snauwaert; Ghent, BE

11:36 O147 Alkaline phosphatase and combined alkaline phosphatase and iPTH influences clinical outcome in peritoneal dialysis patients Z. Chen; Hangzhou, CN

11:48 O148 Clinical investigation of 120 peritoneal dialysis patients combined with extraosseous calcification S. Wang; Hangzhou, CN

12:00 O149 Numerical modelling of microcirculation fluid exchanges in uremic patients accounting for the non-linear effect of lymphatic system L. Possenti; Milan, IT

12:12 O150 Which Uremic Toxins are Affecting Vascular Calcification? J. Holmar; Aachen, DE

12:24 Discussion


C32 Tissue Engineering & Regenerative Medicine IV

Chair 1 G. Catapano; Rende, IT Chair 2 A. Campbell Ritchie; Nottingham, GB 11:00 O151 Strategies for the expansion and

differentiation of human mesenchymal stem cells under physiological conditions C. Kasper; Vienna, AT

11:20 O152 3D oxygen transport model in strips of ovarian cortical tissue: a basic tool for assisted reproduction techniques G. Falvo D'Urso Labate; Rende, IT

11:32 O153 Fiber size and composition as tools to manipulate wettability and compliance of electrospun tubular scaffolds to enhance tissue regeneration. M. Mueller; Hanover, DE

11:44 O154 Laser engraving promotes the repopulation of decellularized articular cartilage S. Nürnberger; Vienna, AT

11:56 O155 Regeneration and Osteointegration of the Anterior Cruciate Ligament using a Novel Silk Fiber based Scaffold T. Nau; Vienna, AT

12:08 O156 Development of Injectable Cell Scaffold for Cell Therapy T. Furuzono; Kinokawa, Wakayama, JP

12:20 Discussion

ESAO-IFAO 2017 – Program Saturday, September 9 – Morning Sessions

40


D32 Ventricular Assist Devices: The next Generation

Chair 1 T. Masuzawa; Hitachi, JP Chair 2 J. Canizo; Madrid, ES 11:00 O157 Relationship between fluid force

fluctuation and impeller design for magnetically levitated centrifugal blood pumps T. Masuzawa; Hitachi, JP

11:15 O158 Development of a hydrodynamically levitated centrifugal blood pump for long-term extracorporeal mechanical circulatory support systems T. Tsukiya; Suita, JP

11:30 O159 A Novel, Miniaturized VAD Configured for Right-Heart MCS J. Stanfield; Salt Lake City, US

11:45 O160 Novel Pediatric Axial Rotary Blood Pump D. Telyshev; Moscow, RU

12:00 O161 Development of a Miniature, Hemocompatible Continuous Flow Pediatric Ventricular Assist Device J. Stanfield; Salt Lake City, US

12:15 O162 Next generation ultracompact centrifugal pediatric VAD with full axis controlled maglev motor M. Osa; Hitachi, JP


CC Closing Ceremony Chair 1 T. Groth; Halle, DE Chair 2 H. Schima; Vienna, AT 12:30 Closing Remarks: ESAO President

C. Legallais; Compiegne, FR 12:35 Closing Remarks: IFAO President

B. Stegmayr; Umea, SE 12:40 Presentation of the ESAO Innovation Award and

the ESAO Poster Awards

12:50 Announcement of the next IFAO Congress

12:55 Announcement of the next ESAO Congress J. Canizo; Madrid, ES

Saturday, September 9 / 13:00 / Hall 1 13:00 Farewell Lunch

Gulasch, Wiener Würstel and Beer

ESAO-IFAO 2017 Notes

41

ESAO-IFAO 2017 Notes

42

yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULES!! yESAO RULE S!! yESAO RULES!! yESAO RU

ESAO-IFAO 2017 Impressum

43

Impressum Responsible for the Content: Prof. H. Schima, Ludwig Boltzmann Cluster for Cardiovascular Research p.A. General Hospital of Vienna/ Level 4L, 1090 Austria Organizing Institution: Ludwig Boltzmann Gesellschaft Nußdorferstr. 64, 6. Stock A-1090 Wien Tel: +43 1 5132750 Fax: +43 1 5132310 Email: [email protected]

Congress Agency: Conventive OG Leopold-Gattringerstr. 7/10 2345 Brunn am Gebirge Tel: +43 2236 38 27 32 Fax: +43 274 222 210 015 Mail: [email protected]

DISCLAIMER All the best endeavors will be made by Organizers to implement the program of the ESAO 2017 Congress as it is announced here. However, no warranty is given whatsoever that the presented program will be in full agreement with the printed one. The Organizers reserve the right to alter or cancel, without prior notice, any of the arrangements, timetables, plans or other items relating directly or indirectly to the Congress, for any reasons beyond their reasonable control.

esao-ifao · pdf fileafter decades of development, the artificial and...

Documents